Oxirane

Oxirane

SCHEMBL7119447

C1CO1.COc1ccc(C#N)cc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
GSK3B P49841 1/20 0.48
ALDH1A1 P00352 4/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
THRB P10828 1/20 0.44
APP P05067 2/20 0.44
MAPKAPK2 P49137 1/20 0.43
HRH3 Q9Y5N1 2/20 0.43
HRH2 P25021 1/20 0.43
HRH1 P35367 1/20 0.43
CYP2A6 P11509 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL103904 0.89 MAOB (0.61) MAOAMAOBGSK3BALDH1A1CA12
SCHEMBL30757515 0.89 MAOB (0.61) MAOAMAOBGSK3BALDH1A1CA12
1,4-Dimethoxybenzene SCHEMBL28617696 0.89 MAOB (0.61) MAOAMAOBGSK3BALDH1A1CA12
SCHEMBL30250275 0.87 MAOA (0.59) MAOAMAOBGSK3BALDH1A1CA12
SCHEMBL91929 0.83 MAOA (0.56) MAOAMAOBGSK3BALDH1A1CA12
SCHEMBL921496 0.83 MAOA (0.56) MAOAMAOBGSK3BALDH1A1CA12
SCHEMBL3419967 0.83 MAOA (0.56) MAOAMAOBGSK3BALDH1A1CA12
SCHEMBL13863705 0.83 APP (0.63) MAOAMAOBGSK3BALDH1A1CA12
SCHEMBL7828090 0.81 MAOA (0.54) MAOAMAOBGSK3BALDH1A1CA12
SCHEMBL13241213 0.80 MAOA (0.50) MAOAMAOBGSK3BALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6566360-B1 Administering 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position for therapy of hypertrophy of the prostate, incontinence or female sexual dysfunction in mammals BAYER AKTIENGESELLSCHAFT (DE) 2003-05-20 US disclosed